164 related articles for article (PubMed ID: 15696244)
21. Edifoligide and long-term outcomes after coronary artery bypass grafting: PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) 5-year results.
Lopes RD; Williams JB; Mehta RH; Reyes EM; Hafley GE; Allen KB; Mack MJ; Peterson ED; Harrington RA; Gibson CM; Califf RM; Kouchoukos NT; Ferguson TB; Lorenz TJ; Alexander JH
Am Heart J; 2012 Sep; 164(3):379-386.e1. PubMed ID: 22980305
[TBL] [Abstract][Full Text] [Related]
22. Graft type for femoro-popliteal bypass surgery.
Ambler GK; Twine CP
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD001487. PubMed ID: 29429146
[TBL] [Abstract][Full Text] [Related]
23. A Randomized Controlled Trial Comparing Crude Versus Heparin-Bonded PTFE Graft in Below the Knee Bypass Surgery for Critical Limb Ischemia (REPLACE Trial): Design and Protocol.
Gouëffic Y; Favre JP; Steinmetz E; Ordureau A; Riche VP; Guyomarch B; Rosset E
Ann Vasc Surg; 2019 Jul; 58():115-121. PubMed ID: 30769063
[TBL] [Abstract][Full Text] [Related]
24. Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia.
Schanzer A; Hevelone N; Owens CD; Beckman JA; Belkin M; Conte MS
J Vasc Surg; 2008 Apr; 47(4):774-781. PubMed ID: 18381138
[TBL] [Abstract][Full Text] [Related]
25. Midterm results of autologous saphenous vein and ePTFE pre-cuffed bypass surgery in peripheral arterial occlusive disease.
Donker JM; Ho GH; Te Slaa A; de Groot HG; van der Waal JC; Veen EJ; van der Laan L
Vasc Endovascular Surg; 2011 Oct; 45(7):598-603. PubMed ID: 21757494
[TBL] [Abstract][Full Text] [Related]
26. A personal experience with the influence of diabetes and other factors on the outcome of infrainguinal bypass grafts for occlusive disease.
Hertzer NR; Bena JF; Karafa MT
J Vasc Surg; 2007 Aug; 46(2):271-279. PubMed ID: 17600656
[TBL] [Abstract][Full Text] [Related]
27. Outcome of infrainguinal single-segment great saphenous vein bypass for critical limb ischemia is superior to alternative autologous vein bypass, especially in patients with high operative risk.
Arvela E; Venermo M; Söderström M; Albäck A; Lepäntalo M
Ann Vasc Surg; 2012 Apr; 26(3):396-403. PubMed ID: 22285375
[TBL] [Abstract][Full Text] [Related]
28. Outcome after occlusion of infrainguinal bypasses in the Dutch BOA Study: comparison of amputation rate in venous and prosthetic grafts.
Smeets L; Ho GH; Tangelder MJ; Algra A; Lawson JA; Eikelboom BC; Moll FL;
Eur J Vasc Endovasc Surg; 2005 Dec; 30(6):604-9. PubMed ID: 16098774
[TBL] [Abstract][Full Text] [Related]
29. Factors associated with primary vein graft occlusion in a multicenter trial with mandated ultrasound surveillance.
Oresanya L; Makam AN; Belkin M; Moneta GL; Conte MS
J Vasc Surg; 2014 Apr; 59(4):996-1002. PubMed ID: 24361199
[TBL] [Abstract][Full Text] [Related]
30. Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery.
Bedenis R; Lethaby A; Maxwell H; Acosta S; Prins MH
Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD000535. PubMed ID: 25695213
[TBL] [Abstract][Full Text] [Related]
31. Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery.
Dörffler-Melly J; Büller HR; Koopman MM; Prins MH
Cochrane Database Syst Rev; 2003; (4):CD000536. PubMed ID: 14583924
[TBL] [Abstract][Full Text] [Related]
32. Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass.
Lumsden AB; Morrissey NJ;
J Vasc Surg; 2015 Mar; 61(3):703-12.e1. PubMed ID: 25720929
[TBL] [Abstract][Full Text] [Related]
33. Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery.
Geraghty AJ; Welch K
Cochrane Database Syst Rev; 2011 Jun; 2011(6):CD000536. PubMed ID: 21678330
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of edifoligide.
Desai ND; Fremes SE
JAMA; 2006 Apr; 295(13):1514; author reply 1514-5. PubMed ID: 16595752
[No Abstract] [Full Text] [Related]
35. Efficacy and safety of edifoligide.
Lau GT; Kritharides L
JAMA; 2006 Apr; 295(13):1513-4; author reply 1514-5. PubMed ID: 16595750
[No Abstract] [Full Text] [Related]
36. Efficacy and safety of edifoligide.
Parolari A; Alamanni F; Tremoli E; Biglioli P
JAMA; 2006 Apr; 295(13):1513; author reply 1514-5. PubMed ID: 16595751
[No Abstract] [Full Text] [Related]
37. Disparity in outcomes of surgical revascularization for limb salvage: race and gender are synergistic determinants of vein graft failure and limb loss.
Nguyen LL; Hevelone N; Rogers SO; Bandyk DF; Clowes AW; Moneta GL; Lipsitz S; Conte MS
Circulation; 2009 Jan; 119(1):123-30. PubMed ID: 19103988
[TBL] [Abstract][Full Text] [Related]
38. The natural history of stenoses within lower limb arterial bypass grafts using a graft surveillance program.
Carter A; Murphy MO; Halka AT; Turner NJ; Kirton JP; Murray D; Bodill H; Millar ML; Mason T; Smyth JV; Walker MG
Ann Vasc Surg; 2007 Nov; 21(6):695-703. PubMed ID: 17980793
[TBL] [Abstract][Full Text] [Related]
39. Bypass Surgery With Heparin-Bonded Grafts for Chronic Lower Limb Ischemia.
McAnelly SL; Hajibandeh S; Hajibandeh S; Georgiadis GS; Antoniou SA; Madan M; Antoniou GA
Ann Vasc Surg; 2017 Aug; 43():328-346. PubMed ID: 28478165
[TBL] [Abstract][Full Text] [Related]
40. Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia.
Nguyen LL; Moneta GL; Conte MS; Bandyk DF; Clowes AW; Seely BL;
J Vasc Surg; 2006 Nov; 44(5):977-83; discussion 983-4. PubMed ID: 17098529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
